Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.

Chen BP, Fraser C, Reading C, Murray L, Uchida N, Galy A, Sasaki D, Tricot G, Jagannath S, Barlogie B, et al.

Leukemia. 1995 Oct;9 Suppl 1:S17-25.

PMID:
7475307
2.

Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.

Murray L, Chen B, Galy A, Chen S, Tushinski R, Uchida N, Negrin R, Tricot G, Jagannath S, Vesole D, et al.

Blood. 1995 Jan 15;85(2):368-78.

3.

Analysis of human hematopoietic stem cell populations.

Murray L, DiGiusto D, Chen B, Chen S, Combs J, Conti A, Galy A, Negrin R, Tricot G, Tsukamoto A.

Blood Cells. 1994;20(2-3):364-9; discussion 369-70.

PMID:
7538340
4.

CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.

Young JC, Lin K, Hansteen G, Travis M, Murray LJ, Jaing L, Scollay R, Hill BL.

Exp Hematol. 1999 Jun;27(6):994-1003.

PMID:
10378888
5.

CD34+Thy-1+Lin- stem cells from mobilized peripheral blood.

Murray LJ, Tsukamoto A, Hoffman R.

Leuk Lymphoma. 1996 Jun;22(1-2):37-42, follow. 186, color plate I. Review.

PMID:
8724526
6.

Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft.

Fraser CC, Kaneshima H, Hansteen G, Kilpatrick M, Hoffman R, Chen BP.

Blood. 1995 Sep 1;86(5):1680-93.

7.

Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.

Van den Berg D, Wessman M, Murray L, Tong J, Chen B, Chen S, Simonetti D, King J, Yamasaki G, DiGiusto R, Gearing D, Reading C.

Blood. 1996 May 15;87(10):4348-57.

8.

Biological characterization of stem cell present in mobilized peripheral blood of CML patients.

Tsukamoto AS, Reading C, Carella A, Frassoni F, Gorin C, LaPorte J, Negrin R, Blume K, Cunningham I, Deisseroth A, et al.

Bone Marrow Transplant. 1994;14 Suppl 3:S25-32.

PMID:
7535151
9.

Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep.

Sutherland DR, Yeo EL, Stewart AK, Nayar R, DiGiusto R, Zanjani E, Hoffman R, Murray LJ.

Exp Hematol. 1996 Jun;24(7):795-806.

PMID:
8647230
10.

Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities.

Uchida N, Combs J, Chen S, Zanjani E, Hoffman R, Tsukamoto A.

Blood. 1996 Aug 15;88(4):1297-305.

12.

Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.

Gazitt Y, Reading CC, Hoffman R, Wickrema A, Vesole DH, Jagannath S, Condino J, Lee B, Barlogie B, Tricot G.

Blood. 1995 Jul 1;86(1):381-9.

13.

Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice.

Chen BP, Galy A, Kyoizumi S, Namikawa R, Scarborough J, Webb S, Ford B, Cen DZ, Chen SC.

Blood. 1994 Oct 15;84(8):2497-505.

14.
15.

Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma.

Vose JM, Bierman PJ, Lynch JC, Atkinson K, Juttner C, Hanania CE, Bociek G, Armitage JO.

Biol Blood Marrow Transplant. 2001;7(12):680-7.

16.

Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.

Michallet M, Philip T, Philip I, Godinot H, Sebban C, Salles G, Thiebaut A, Biron P, Lopez F, Mazars P, Roubi N, Leemhuis T, Hanania E, Reading C, Fine G, Atkinson K, Juttner C, Coiffier B, Fière D, Archimbaud E.

Exp Hematol. 2000 Jul;28(7):858-70.

PMID:
10907648
17.

Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.

Hess DA, Levac KD, Karanu FN, Rosu-Myles M, White MJ, Gallacher L, Murdoch B, Keeney M, Ottowski P, Foley R, Chin-Yee I, Bhatia M.

Blood. 2002 Aug 1;100(3):869-78.

18.

Delineation of T-progenitor cell activity within the CD34+ compartment of adult bone marrow.

Galy AH, Cen D, Travis M, Chen S, Chen BP.

Blood. 1995 May 15;85(10):2770-8.

19.

The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .

Haas R, Murea S.

Cytokines Mol Ther. 1995 Dec;1(4):249-70. Review. Erratum in: Cytokines Mol Ther 1996 Mar;2(1):136.

PMID:
9384679
20.

Supplemental Content

Support Center